Details of the Drug Reposition

General Information of This Drug (ID: DMT8WXM)

• Drug Name: FATE-NK100 (DMT8WXM)

Information on Drug Reposition of This Drug

3 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1	[1]
Acute myeloid leukaemia	DIS0BM1I	2A60	Phase 1	[1]
Ovarian cancer	DISZJHAP	2C73	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)